Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival
Objective: To examine the prognostic value of tumor major histocompatibility complex I (MHCI) expression on survival and recurrence in patients with clear cell renal cell carcinoma (RCC). Methods: Fifty-three patients that underwent nephrectomy at our institution for clear cell RCC (T1–T3) with ≥4 y...
Main Authors: | Rishi R. Sekar, Claire M. De La Calle, Dattatraya Patil, Sarah A. Holzman, Yoram Baum, Umer Sheikh, Jonathan H. Huang, Adeboye O. Osunkoya, Brian P. Pollack, Haydn T. Kissick, Kenneth Ogan, Viraj A. Master |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-04-01
|
Series: | Asian Journal of Urology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388216000187 |
Similar Items
-
Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma
by: Kyu Seo Kim, et al.
Published: (2018-04-01) -
Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
by: Yoram S. Baum, et al.
Published: (2016-01-01) -
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma
by: Rishi R. Sekar, et al.
Published: (2017-10-01) -
Minor Histocompatibility Antigen-Specific T Cells
by: Corinne Summers, et al.
Published: (2020-06-01) -
Major histocompatibility complex and stem cells
by: Laguna Goya, Rocío
Published: (2010)